EQS Group-News: MetrioPharm AG / Key word(s): Conference/Study results MetrioPharm AG: MetrioPharm Presents Clinical Phase IIa Psoriasis Study Data at the 5th WPPAC in Stockholm 26.06.2018 / 12:40 698769 26.06.2018 ...
EQS Group-News: MetrioPharm AG / Key word(s): Study/Miscellaneous MetrioPharm AG: First patient dosed in a clinical Phase II trial for MP1032 for the treatment of moderate-to-severe chronic plaque psoriasis 07.03.2018 / 18:29 661563 07.03.2018 ...
EQS Group-News: MetrioPharm AG / Key word(s): Study results MetrioPharm Announces Positive Top-Line Results from a Phase IIa Study in Moderate-to-Severe Psoriasis with its Oral Lead Compound MP1032 14.03.2017 / 10:20 553769 14.03.2017 ...